New rapid test could slash unnecessary antibiotic use in emergency rooms
NCT ID NCT06271655
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a fast point-of-care PCR test (Spotfire) that quickly identifies whether a respiratory infection is caused by a virus. The goal is to give ER doctors results faster so they can avoid prescribing antibiotics when they won't help. The trial enrolls 200 adults with symptoms of acute respiratory infection lasting less than 14 days.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- SPOTFIRE R Panel (rapid point-of-care PCR test)
- What this could lead to
- If successful, this rapid test could help doctors avoid prescribing antibiotics for viral infections, reducing antibiotic resistance and improving patient care.
- What could go wrong
- This is a small, single-arm study with 200 participants, so results may not apply broadly. The test's impact on antibiotic use depends on how doctors act on the results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Can immune profiling unlock the hidden stages of tuberculosis?
- Scientists compare immune responses to viral and bacterial infections in ICU patients
- Newborn blood spots may reveal hidden risks from common virus
- Banked immune cells show promise against Life-Threatening viruses in transplant patients
- New ibuzatrelvir tablet put to the test in healthy volunteers